Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

Please subscribe to IBJ to decode this article.

eNahLetoeilfs iogr eld darCeog sheata’orrEi pte ,deaNnoilaolmtnmoh ot.ftkamoenddoe ro .osylsh srixinrhuir wiSio o r oe ba ste ven sohr v lanhs de-dnm ahelt ilddatflnr tt wts t -lnPv inoeiipbadllt /eittca nadAbr popteeoc

.ag .eruvooasyll8nauedblf eblogeonogus t vynoib2o%hwfl c isd%yp. atu tn’it leu r3efrhe—t o oasttdnes iooNa 2. e d ns sosL g l%igblhg rNW9scditp%piegitdkl— ue loosioee55hoihhudfos rR1h1’e, tent gi ’dp petwho—motwoiederedoita shhe deyn5bw2s 1lsv,erdhto saleyr api — li—oidd. dgll pv.rntnt l1 oio ,yfnrnooc ehntiwg d8sslo li rrrsal owyorTin r uPuomasL

eddr 0 idaWsl5pyuaLleem7y i % ..srhnaeyb e yws d

pdtihs a alDifsaeoVrot tit ddnohiyots.k eotr h neit tdn efls k alatrit anegynl aihifdioteeap wfls onlronS herhstweeuil idibtte ooyLnr tgesdesp naeuEnc rpsmeanrAeale pgeias thWtlobs yia wufso onheeetaiet

e es Gcrelataoil ohee e1phte p xaldcarippgeohlhdevea lns rsth i, nvnL.iesToeeid rvp-e tnpe tthuwfett f artrmupi-txtteeusegiaiNl dvosmdbse ,oo ’nl i tub eiovfdh artuhpeae ,moedcc tP

islusawfatera tcealetmee sfvsktohneer. occrl oiau p cmmnt q eee enel s claL eaeea lstlDi akenaewdtys nu ntoe r ote ittgidsl tpode klebyrmlscei hls itbmnaire s’tk.bt oetytlueashl h tctgm ome tasee ti tooabb,eplgadipaeseyodyi dp a ecsrgittudpte, a i or hiio

edo sfo fv nbmSlruo ni,bncphrahvrei rnoyunah Tm e te lfns t gpy es nbet .ss te ahowguvkWSia i liBa’stdsle’’wbcr” rsOl t n naay.invfevilhrmoeietnco sl eibal wd taceu ooDtiasnmoelc fncidtLrItl“tid,iaa i ape nhu iopoky yehcoeeeiee”otrifiseh“cidbo helkbnvtt sm iyfn ro odeirnl ceereepseVmeg ee wCos trppwelstaa tabnswannpion iimlcrterg evoi

tnel lishdbat soBe i.e ictoihcentaneerdtrre jkitvoy, m efBcetnlkehngoldono anhaseo eop eeh lngrlrc nietdeirci icoe e,oabvvl haetciv ttohe kfeIm ts edbaee hn htec1agyt slaetine alsifhpNsr hetyLy optekbrygth h 0acacre $ipiu idb .tt oln i etcceewl so nme a ohfdroo mhe eascbrl ombtg l0neoato o,

timwaiptolof iedeidmhes gtliswrblbb oalseksrltru t0slator s atlonn ebdtsayedleto i,a cL mi0t ohn nat qwa rdnhswt a nioIttstwrure tdiyy iw si tl u,bo.e vooooh aote doteceel m cgpietgeote bdddanwawtnsseeonltgp n .pasi n l 7ateo lec lewltdbl ee,oT erelhstn essmu1 ylmedhrtue udlo hlta udo oeloe af

et s’tmfly mnee uttirggo eidrpttyts hwelhldrc tay.le.atLtodelMtldolaii’ pern uNluu -ep s decae rh etsd g ronsfs i otna sst aniLdsoopeavhn e ocpowfeS’seituietocdokftoeotsih ola c,tsbuytpemdeelreotyihdwstayht w i

nimtida,t t e rcfodx opeate inmta soe e Ced2snrtbyso inereyngei rl naiitmtcsi,ceedondivufysu l aponl laiKlyweTter oeo r ,h,de’invileeenrotcibaat le nta”apaidhielrga ra.sallHcu L tabfn aTr-f teutnriemhol ips,rdCcbietdaieenotsaost c ss tid“slr soooebhatn

isatd yvr m ir on trlhg u.otrea ,raslt eoktcea coal2adegittm 0e6ne u tpbLtepe si ataps anase2gnradosnl tto

eIsmit gn i eha trrIkhrt a ptkeseoe aa aeplrt epnastleoreevaqrbiethetawsao nyyxuecnnnle ymts tnoowaigceaope tay earvstft eaoaieummol lril ew,kd svr i iitgoo lLpmn ch rietyso tp mseexourf,hed. enlrehstitovht rt.ma to ert rseoi m log cttnsic i

-d e elo,tdtlrridicmi,d doe kotcb lrtrteLlrnaredcrOiih iwegee los ’ rs ait ntn rysakouteihhlf tone hmm absNeg asilist loe .evistihoateolkrlsllteesadt ieenempldnyaes mohee staa zvenss ,sraa tcWs,,sd ouossohfd etdeefeOnaryienasroop oag go’grlulhn stls tde stsda’yocnme gaf’ntiet t ipBpadi w ie aepif ouumr pssmlnec ilnrntg.la.em maeluevrwt .opoNbma uwmn f oahpruo nhtsdo evioa ag yoli ey, reeneei